메뉴 건너뛰기




Volumn 19, Issue 6, 2009, Pages 1062-1067

Prognostic impact of parity in 493 uterine sarcoma patients

Author keywords

Histological subtype; Parity; Prognosis; Uterine sarcomas

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BIRTH; CANCER SURVIVAL; CARCINOSARCOMA; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LEIOMYOSARCOMA; LOG RANK TEST; MAJOR CLINICAL STUDY; NORWAY; NULLIPARA; PARITY; PRIORITY JOURNAL; PROGNOSIS; REGISTER; UTERUS SARCOMA;

EID: 70349230913     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181aaa950     Document Type: Article
Times cited : (15)

References (29)
  • 1
    • 37549048643 scopus 로고    scopus 로고
    • The management of patients with uterine sarcoma: A debated clinical challenge
    • Gadducci A, Cosio S, Romanini A, et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008;65:129-142.
    • (2008) Crit Rev Oncol Hematol. , vol.65 , pp. 129-142
    • Gadducci, A.1    Cosio, S.2    Romanini, A.3
  • 2
    • 35348872771 scopus 로고    scopus 로고
    • Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: A comparison with uterine endometrial adenocarcinoma
    • Akahira J-i, Tokunaga H, Toyoshima M, et al. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Oncology. 2006;71:333-340.
    • (2006) Oncology , vol.71 , pp. 333-340
    • Akahira, J.-I.1    Tokunaga, H.2    Toyoshima, M.3
  • 5
    • 37349016186 scopus 로고    scopus 로고
    • Prognostic features of surgical stage I uterine carcinosarcoma
    • Ferguson SE, Tornos C, Hummer A, et al. Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol. 2007;31:1653-1661.
    • (2007) Am J Surg Pathol. , vol.31 , pp. 1653-1661
    • Ferguson, S.E.1    Tornos, C.2    Hummer A3
  • 6
    • 0028979636 scopus 로고
    • Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: A comparative analysis of survival
    • George E, Lillemoe TJ, Twiggs LB, et al. Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol. 1995;14:39-44.
    • (1995) Int J Gynecol Pathol. , vol.14 , pp. 39-44
    • George, E.1    Lillemoe, T.J.2    Twiggs, L.B.3
  • 7
    • 22544455338 scopus 로고    scopus 로고
    • Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer
    • Amant F, Cadron I, Fuso L, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol. 2005;98:274-280.
    • (2005) Gynecol Oncol. , vol.98 , pp. 274-280
    • Amant, F.1    Cadron, I.2    Fuso, L.3
  • 8
    • 33750160521 scopus 로고    scopus 로고
    • Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma
    • Vaidya AP, Horowitz NS, Oliva E, et al. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Gynecol Oncol. 2006;103:684-687.
    • (2006) Gynecol Oncol. , vol.103 , pp. 684-687
    • Vaidya, A.P.1    Horowitz, N.S.2    Oliva, E.3
  • 9
    • 0032055150 scopus 로고    scopus 로고
    • Poorer survival of nulliparous women with endometrial carcinomas
    • Salvesen HB, Akslen A, Albrektsen G, et al. Poorer survival of nulliparous women with endometrial carcinomas. Cancer. 1998;82: 1328-1333.
    • (1998) Cancer , vol.82 , pp. 1328-1333
    • Salvesen, H.B.1    Akslen, A.2    Albrektsen, G.3
  • 10
    • 67651021228 scopus 로고    scopus 로고
    • Parity and time interval since childbirth influence survival in endometrial cancer patients
    • Albrektsen G, Heuch I, Wik E, et al. Parity and time interval since childbirth influence survival in endometrial cancer patients. Int J Gynecol Cancer. 2009;19:665-669.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 665-669
    • Albrektsen, G.1    Heuch, I.2    Wik, E.3
  • 11
    • 0031013017 scopus 로고    scopus 로고
    • Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium
    • Marth C, Windbichler G, Petru E, et al. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol. 1997;64:121-125.
    • (1997) Gynecol Oncol. , vol.64 , pp. 121-125
    • Marth, C.1    Windbichler, G.2    Petru, E.3
  • 12
    • 0031455206 scopus 로고    scopus 로고
    • An evaluation of prognostic factors in uterine carcinosarcoma
    • Nordal RR, Kristensen GB, Stenwig AE, et al. An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol. 1997;67:316-321.
    • (1997) Gynecol Oncol. , vol.67 , pp. 316-321
    • Nordal, R.R.1    Kristensen, G.B.2    Stenwig, A.E.3
  • 13
    • 0035169864 scopus 로고    scopus 로고
    • Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study
    • Bodner-Adler B, Bodner K, Obermair A, et al. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Anticancer Res. 2001;21:3069-3084.
    • (2001) Anticancer Res. , vol.21 , pp. 3069-3084
    • Bodner-Adler, B.1    Bodner, K.2    Obermair, A.3
  • 15
    • 25144474865 scopus 로고    scopus 로고
    • The expression of Ki67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas: A clinicopathologic study
    • Akhan SE, Yavuz E, Tecer A, et al. The expression of Ki67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas: a clinicopathologic study. Gynecol Oncol. 2005;99:36-42.
    • (2005) Gynecol Oncol. , vol.99 , pp. 36-42
    • Akhan, S.E.1    Yavuz, E.2    Tecer, A.3
  • 17
    • 35649027850 scopus 로고    scopus 로고
    • Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma
    • Amant F, De Knijf A, Van Calster B, et al. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer. 2007;97: 1194-1199.
    • (2007) Br J Cancer , vol.97 , pp. 1194-1199
    • Amant, F.1    De Knijf, A.2    Van Calster, B.3
  • 19
    • 33846785509 scopus 로고    scopus 로고
    • Early-stage carcinosarcoma of the uterus: The significance of lymph node count
    • Temkin SM, Hellmann M, Lee Y-C, et al. Early-stage carcinosarcoma of the uterus: the significance of lymph node count. Int J Gynecol Cancer. 2007;17:215-219.
    • (2007) Int J Gynecol Cancer , vol.17 , pp. 215-219
    • Temkin, S.M.1    Hellmann, M.2    Lee, Y.-C.3
  • 20
    • 52049118515 scopus 로고    scopus 로고
    • Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis
    • Nemani D, Mitra N, Guo M, et al. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol. 2008;111:82-88.
    • (2008) Gynecol Oncol. , vol.111 , pp. 82-88
    • Nemani, D.1    Mitra, N.2    Guo, M.3
  • 21
    • 33745084836 scopus 로고    scopus 로고
    • Clinical outcomes of uterine sarcomas: Results from 14 years worth of experience in the Kinki district in Japan (1990-2003)
    • Kokawa K, Nishiyama K, Ikeuchi M, et al. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990Y2003). Int J Gynecol Cancer. 2006;16:1358-1363.
    • (2006) Int J Gynecol Cancer , vol.16 , pp. 1358-1363
    • Kokawa, K.1    Nishiyama, K.2    Ikeuchi, M.3
  • 22
    • 33846534068 scopus 로고    scopus 로고
    • Prognostic factors and outcome in women with uterine sarcoma
    • Denschlag D, Masoud I, Stanimir G, et al. Prognostic factors and outcome in women with uterine sarcoma. EJSO. 2007;33:91-95.
    • (2007) EJSO , vol.33 , pp. 91-95
    • Denschlag, D.1    Masoud, I.2    Stanimir, G.3
  • 23
    • 52049107071 scopus 로고    scopus 로고
    • Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990-2001
    • Koivisto-Korander R, Butzow R, Koivisto A-M, et al. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Gynecol Oncol. 2008; 111:74-81.
    • (2008) Gynecol Oncol. , vol.111 , pp. 74-81
    • Koivisto-Korander, R.1    Butzow, R.2    Koivisto, A.-M.3
  • 24
    • 54949157193 scopus 로고    scopus 로고
    • Prognostic factors and treatment outcomes of patients with uterine sarcoma: Analysis of 127 patients at a single institution 1989-2007
    • Park J-Y, Kim D-Y, Suh D-S, et al. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. J Cancer Res Clin Oncol. 2008;134: 1277-1287.
    • (2008) J Cancer Res Clin Oncol. , vol.134 , pp. 1277-1287
    • Park, J.-Y.1    Kim, D.-Y.2    Suh, D.-S.3
  • 25
    • 42949102222 scopus 로고    scopus 로고
    • Retrospective analysis of 105 cases with uterine sarcoma
    • Yoney A, Eren B, Eskici S, et al. Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer. 2008;95:E10-E17.
    • (2008) Bull Cancer , vol.95
    • Yoney, A.1    Eren, B.2    Eskici, S.3
  • 26
    • 0030744043 scopus 로고    scopus 로고
    • Uterine sarcomas in Norway 1956-1992: Incidence, survival and mortality
    • Nordal RR, Thoresen SK. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer. 1997;33:907-911.
    • (1997) Eur J Cancer. , vol.33 , pp. 907-911
    • Nordal, R.R.1    Thoresen, S.K.2
  • 27
    • 0030221149 scopus 로고    scopus 로고
    • The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma
    • Nordal RR, Kristensen GB, Kaern J, et al. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol. 1996;62: 254-259.
    • (1996) Gynecol Oncol. , vol.62 , pp. 254-259
    • Nordal, R.R.1    Kristensen, G.B.2    Kaern, J.3
  • 28
    • 36348945755 scopus 로고    scopus 로고
    • Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma
    • Huang GS, Chiu LG, Gebb JS, et al. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol. 2007;107:513-517.
    • (2007) Gynecol Oncol. , vol.107 , pp. 513-517
    • Huang, G.S.1    Chiu, L.G.2    Gebb, J.S.3
  • 29
    • 53849101802 scopus 로고    scopus 로고
    • Endometrial stromal sarcoma: A population-based analysis
    • Chan JK, Kawar NM, Shin JY, et al. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008;99:1210-1215.
    • (2008) Br J Cancer , vol.99 , pp. 1210-1215
    • Chan, J.K.1    Kawar, N.M.2    Shin, J.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.